Admission of Further Securities to Trading

Summary by AI ^BETAClose X

Maven Income and Growth VCT 5 PLC announced the admission of 348,359 new Ordinary Shares of 10p each to trading on the London Stock Exchange's Main Market on 21 January 2026. These shares, issued under the Company's Dividend Investment Scheme, are fully fungible with existing Ordinary Shares, bringing the total number of securities in issue to 240,242,270. This admission follows a previous announcement on 16 January 2026 regarding the allotment of these new Ordinary Shares.

Disclaimer*

Maven Income and Growth VCT 5 PLC

21 January 2026

Maven Income and Growth VCT 5 PLC (the Company)
Notification of Admission of Further Securities to Trading (PRM 1.6.4R)

Further to the Company's Issue of Equity announcement on 16 January 2026 in respect of the allotment of new Ordinary Shares under the Company's Dividend Investment Scheme and following the admission to trading of those new Ordinary Shares, the following additional information is disclosed in accordance with The Public Offers and Admissions to Trading Regulations 2024 (POATRs) PRM 1.6.4R.

1	Details of the issuer
a)	Name	Maven Income and Growth VCT 5 PLC
b)	LEI	213800DMF84841RMWX35
2	Details of the transferable securities admitted to trading
a)	Name, type and identification code	Ordinary Shares of 10p each ISIN: GB0002057536
b)	Regulated market	London Stock Exchange - Main Market
c)	Number of further securities admitted	348,359
d)	Total number of securities in issue following admission	240,242,270
e)	Fungibility	Fully fungible with existing Ordinary Shares
3	Admission details
a)	Date of admission	21 January 2026
b)	Prospectus information	Prospectus: N/A Supplementary: N/A Company's webpage: www.mavencp.com/migvct5
c)	Coverage of notification	All admissions up to and including 21 January 2026
4	Contact details
a)	Name and contact number	Company Secretary, Maven Capital Partners UK LLP Tel: 0141 306 7400

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END